JAMES GRANT BAILEY, L.AC.
Acupuncture at Montana Ave, Santa Monica, CA

License number
California AC6102
Category
Acupuncture
Type
Acupuncturist
Address
Address 2
1502 Montana Ave SUITE 207, Santa Monica, CA 90403
1522 Michael Ln, Pacific Palisades, CA 90272
Phone
(310) 393-4124

Professional information

James Bailey Photo 1

James Bailey - Santa Monica, CA

Work:
Recreational Equipment Incorporated
Bike repair and Camping Sales Specialist
Historic Home Renovation and Restoration Carpenter BB Jewelry Studio
Manager, Designer, Gold/Platinumsmith
Carpenter - Construction
Designer-Goldsmith Baum Diamonds
Johnny's Pizza
Manager
Edwards Builders and Associates - Greenville, NC
General Carpentry
Joe Pittman, John Bland - Durham, NC
Residential Framing
Robert Tewksberry - Durham, NC
Residential Framing
Residential Repair - Los Angeles, CA
Residential Framing
C.C. Woods Construction Company
Construction Worker
C.C. Woods Construction Company
Construction Worker
Self employed
Residential Painter
Self employed
Lawn Care
Triangle Maintenance
Janitor/Maintenance
Education:
East Carolina University
Bachelor of Fine Arts in Metal Design
North Carolina State University
Electrical and Civil Engineering
Durham Technical College
Vertical Milling and Lathe work
Wake Technical College
Skills:
Carpentry, Construction, Concrete Work, Metal Work, Electrical (non-licensed) Plumbing (non-licensed), Computer Skills; word, photshop, google sketchup, Model Building, Furniture design and construction.


James G Bailey Photo 2

James G Bailey, Santa Monica CA - LAC

Specialties:
Acupuncture
Address:
1502 Montana Ave STE 207, Santa Monica 90403
(310) 393-4124 (Phone), (310) 393-4124 (Fax)
Languages:
English


James Grant Bailey Photo 3

James Grant Bailey, Santa Monica CA

Specialties:
Acupuncturist
Address:
1502 Montana Ave, Santa Monica, CA 90403


James Bailey Photo 4

Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity

US Patent:
2011029, Dec 1, 2011
Filed:
Dec 23, 2010
Appl. No.:
12/977843
Inventors:
Pablo UMANA - Manchester, GB
Joel Jean-Mairet - Barcelona, ES
James E. Bailey - Santa Monica CA, US
Assignee:
Roche GlycArt AG - Schlieren-Zurich
International Classification:
C07K 16/18, C07K 16/40, C12P 21/00, C07K 16/00
US Classification:
5303873, 435 681
Abstract:
The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.


James Bailey Photo 5

Glycosylation Engineering Of Antibodies For Improving Antibody-Dependent Cellular Cytotoxicity

US Patent:
2011014, Jun 16, 2011
Filed:
May 28, 2010
Appl. No.:
12/790716
Inventors:
PABLO UMAÑA - ZURICH, CH
JOËL JEAN-MAIRET - BARCELONA, ES
JAMES E. BAILEY - SANTA MONICA CA, US
M. SEAN BAILEY - SANTA MONICA CA, US
Assignee:
ROCHE GLYCART AG - SCHLIEREN-ZURICH
International Classification:
A61K 39/395, C07K 16/30, A61P 35/00
US Classification:
4241331, 5303873
Abstract:
The present invention relates to the field glycosylation engineering of proteins. More particular, the present invention is directed to the glycosylation engineering of proteins to provide proteins with improved therapeutic properties, e.g., antibodies, antibody fragments, or a fusion protein that includes a region equivalent to the Fc region of an immunoglobulin, with enhanced Fc-mediated cellular cytotoxicity.


James Bailey Photo 6

Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity

US Patent:
8021856, Sep 20, 2011
Filed:
Aug 9, 2005
Appl. No.:
11/199232
Inventors:
Pablo Umaña - Zurich, CH
Joël Jean-Mairet - Barcelona, CH
James E. Bailey - Santa Monica CA, US
Assignee:
Roche GlycArt AG - Zürich
International Classification:
C12P 21/08, A61K 39/395
US Classification:
435 691, 4241301, 435 7021
Abstract:
The present invention relates to the field of glycosylation engineering of proteins. More particularly, the present invention relates to glycosylation engineering to generate proteins with improved therapeutic properties, including antibodies with increased antibody-dependent cellular cytotoxicity.